{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T11:41:36Z","timestamp":1782042096585,"version":"3.54.5"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T00:00:00Z","timestamp":1618790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T00:00:00Z","timestamp":1618790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["00064203"],"award-info":[{"award-number":["00064203"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Working Group of Pediatric Gastroenterology and Nutrition Associated with the Czech Pediatric Society of the Czech Medical Association of J. E. Purkyn\u011b","award":["NA"],"award-info":[{"award-number":["NA"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s00431-021-04077-0","type":"journal-article","created":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T17:03:34Z","timestamp":1618851814000},"page":"3001-3008","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Risk factors for dermatological complications of anti-TNF therapy in a cohort of children with Crohn\u2019s disease"],"prefix":"10.1007","volume":"180","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6193-0488","authenticated-orcid":false,"given":"Ondrej","family":"Hradsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Kazeka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Copova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tereza","family":"Lerchova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina","family":"Mitrova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristyna","family":"Pospisilova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miroslava","family":"Sulovcova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristyna","family":"Zarubova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiri","family":"Bronsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,19]]},"reference":[{"issue":"3","key":"4077_CR1","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1053\/j.gastro.2006.12.003","volume":"132","author":"J Hyams","year":"2007","unstructured":"Hyams J, Crandall W, Kugathasan S, Griffiths A, Olson A, Johanns J, Liu G, Travers S, Heuschkel R, Markowitz J, Cohen S, Winter H, Veereman-Wauters G, Ferry G, Baldassano R (2007) Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn\u2019s disease in children. Gastroenterology 132(3):863\u2013873; quiz 1165-1166. https:\/\/doi.org\/10.1053\/j.gastro.2006.12.003","journal-title":"Gastroenterology"},{"issue":"2","key":"4077_CR2","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1053\/j.gastro.2012.04.046","volume":"143","author":"JS Hyams","year":"2012","unstructured":"Hyams JS, Griffiths A, Markowitz J, Baldassano RN, Faubion WA Jr, Colletti RB, Dubinsky M, Kierkus J, Rosh J, Wang Y, Huang B, Bittle B, Marshall M, Lazar A (2012) Safety and efficacy of adalimumab for moderate to severe Crohn\u2019s disease in children. Gastroenterology 143(2):365\u2013374 e362. https:\/\/doi.org\/10.1053\/j.gastro.2012.04.046","journal-title":"Gastroenterology"},{"issue":"Supplement_1","key":"4077_CR3","doi-asserted-by":"publisher","first-page":"S039","DOI":"10.1093\/ecco-jcc\/jjz203.037","volume":"14","author":"M Jongsma","year":"2020","unstructured":"Jongsma M, Aardoom M, Cozijnsen M, van Pieterson M, de Meij T, Norbruis O, Groeneweg M, Wolters V, van Wering H, Hojsak I, Kolho KL, Hummel T, Stapelbroek J, van der Feen C, Rheenen P, van Wijk M, Teklenburg-Roord S, Escher J, Samsom J, Ridder L (2020) OP38 Top-down infliximab superior to step-up in children with Moderate-to-Severe Crohn\u2019s disease: a multicentre randomised controlled trial. J Crohn's Colitis 14(Supplement_1):S039\u2013S039. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjz203.037","journal-title":"J Crohn's Colitis"},{"key":"4077_CR4","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1093\/ecco-jcc\/jjaa161","volume":"15","author":"PF van Rheenen","year":"2020","unstructured":"van Rheenen PF, Aloi M, Assa A, Bronsky J, Escher JC, Fagerberg UL, Gasparetto M, Gerasimidis K, Griffiths A, Henderson P, Koletzko S, Kolho KL, Levine A, van Limbergen J, Martin de Carpi FJ, Navas-Lopez VM, Oliva S, de Ridder L, Russell RK, Shouval D, Spinelli A, Turner D, Wilson D, Wine E, Ruemmele FM (2020) The medical management of paediatric Crohn\u2019s disease: an ECCO-ESPGHAN Guideline Update. J Crohns Colitis 15:171\u2013194. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjaa161","journal-title":"J Crohns Colitis"},{"issue":"2","key":"4077_CR5","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1053\/j.gastro.2018.04.012","volume":"155","author":"J Kirchgesner","year":"2018","unstructured":"Kirchgesner J, Lemaitre M, Carrat F, Zureik M, Carbonnel F, Dray-Spira R (2018) Risk of serious and opportunistic infections associated with treatment of inflammatory bowel diseases. Gastroenterology 155(2):337\u2013346 e310. https:\/\/doi.org\/10.1053\/j.gastro.2018.04.012","journal-title":"Gastroenterology"},{"issue":"9","key":"4077_CR6","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1038\/ajg.2012.218","volume":"107","author":"GR Lichtenstein","year":"2012","unstructured":"Lichtenstein GR, Feagan BG, Cohen RD, Salzberg BA, Diamond RH, Price S, Langholff W, Londhe A, Sandborn WJ (2012) Serious infection and mortality in patients with Crohn\u2019s disease: more than 5 years of follow-up in the TREAT registry. Am J Gastroenterol 107(9):1409\u20131422. https:\/\/doi.org\/10.1038\/ajg.2012.218","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"4077_CR7","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1038\/ajg.2015.205","volume":"110","author":"E Freling","year":"2015","unstructured":"Freling E, Baumann C, Cuny JF, Bigard MA, Schmutz JL, Barbaud A, Peyrin-Biroulet L (2015) Cumulative incidence of, risk factors for, and outcome of dermatological complications of anti-TNF therapy in inflammatory bowel disease: a 14-year experience. Am J Gastroenterol 110(8):1186\u20131196. https:\/\/doi.org\/10.1038\/ajg.2015.205","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"4077_CR8","doi-asserted-by":"publisher","first-page":"10","DOI":"10.7326\/M15-0729","volume":"164","author":"I Cleynen","year":"2016","unstructured":"Cleynen I, Van Moerkercke W, Billiet T, Vandecandelaere P, Vande Casteele N, Breynaert C, Ballet V, Ferrante M, Noman M, Assche GV, Rutgeerts P, van den Oord JJ, Gils A, Segaert S, Vermeire S (2016) Characteristics of skin lesions associated with anti-tumor necrosis factor therapy in patients with inflammatory bowel disease: a cohort study. Ann Intern Med 164(1):10\u201322. https:\/\/doi.org\/10.7326\/M15-0729","journal-title":"Ann Intern Med"},{"key":"4077_CR9","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1093\/ibd\/izy112","volume":"24","author":"S Sridhar","year":"2018","unstructured":"Sridhar S, Maltz RM, Boyle B, Kim SC (2018) Dermatological manifestations in pediatric patients with inflammatory bowel diseases on anti-TNF therapy. Inflamm Bowel Dis 24:2086\u20132092. https:\/\/doi.org\/10.1093\/ibd\/izy112","journal-title":"Inflamm Bowel Dis"},{"issue":"8","key":"4077_CR10","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1097\/MIB.0000000000000088","volume":"20","author":"T Malkonen","year":"2014","unstructured":"Malkonen T, Wikstrom A, Heiskanen K, Merras-Salmio L, Mustonen H, Sipponen T, Kolho KL (2014) Skin reactions during anti-TNFalpha therapy for pediatric inflammatory bowel disease: a 2-year prospective study. Inflamm Bowel Dis 20(8):1309\u20131315. https:\/\/doi.org\/10.1097\/MIB.0000000000000088","journal-title":"Inflamm Bowel Dis"},{"key":"4077_CR11","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1097\/MPG.0000000000002349","volume":"69","author":"O Courbette","year":"2019","unstructured":"Courbette O, Aupiais C, Viala J, Hugot JP, Louveau B, Chatenoud L, Bourrat E, Martinez-Vinson C (2019) Infliximab paradoxical psoriasis in a cohort of children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 69:189\u2013193. https:\/\/doi.org\/10.1097\/MPG.0000000000002349","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"5","key":"4077_CR12","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1097\/MPG.0b013e31828390ba","volume":"56","author":"ME Sherlock","year":"2013","unstructured":"Sherlock ME, Walters T, Tabbers MM, Frost K, Zachos M, Muise A, Pope E, Griffiths AM (2013) Infliximab-induced psoriasis and psoriasiform skin lesions in pediatric Crohn disease and a potential association with IL-23 receptor polymorphisms. J Pediatr Gastroenterol Nutr 56(5):512\u2013518. https:\/\/doi.org\/10.1097\/MPG.0b013e31828390ba","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"4077_CR13","doi-asserted-by":"publisher","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O'Neal L, McLeod L, Delacqua G, Delacqua F, Kirby J, Duda SN, Consortium RE (2019) The REDCap consortium: Building an international community of software platform partners. J Biomed Inform 95:103208. https:\/\/doi.org\/10.1016\/j.jbi.2019.103208","journal-title":"J Biomed Inform"},{"key":"4077_CR14","unstructured":"Team RC (2020) R: A language and environment for statistical computing R Foundation for Statistical Computing"},{"issue":"4","key":"4077_CR15","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1136\/gutjnl-2012-302853","volume":"63","author":"C Tillack","year":"2014","unstructured":"Tillack C, Ehmann LM, Friedrich M, Laubender RP, Papay P, Vogelsang H, Stallhofer J, Beigel F, Bedynek A, Wetzke M, Maier H, Koburger M, Wagner J, Glas J, Diegelmann J, Koglin S, Dombrowski Y, Schauber J, Wollenberg A, Brand S (2014) Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-gamma-expressing Th1 cells and IL-17A\/IL-22-expressing Th17 cells and respond to anti-IL-12\/IL-23 antibody treatment. Gut 63(4):567\u2013577. https:\/\/doi.org\/10.1136\/gutjnl-2012-302853","journal-title":"Gut"},{"key":"4077_CR16","doi-asserted-by":"publisher","unstructured":"Nigam GB, Bhandare AP, Antoniou GA, Limdi JK (2020) Systematic review and meta-analysis of dermatological reactions in patients with inflammatory bowel disease treated with anti-tumour necrosis factor therapy. Eur J Gastroenterol Hepatol Publish Ahead of Print. https:\/\/doi.org\/10.1097\/MEG.0000000000001917","DOI":"10.1097\/MEG.0000000000001917"},{"issue":"3","key":"4077_CR17","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1056\/NEJMoa1104200","volume":"365","author":"S Eyerich","year":"2011","unstructured":"Eyerich S, Onken AT, Weidinger S, Franke A, Nasorri F, Pennino D, Grosber M, Pfab F, Schmidt-Weber CB, Mempel M, Hein R, Ring J, Cavani A, Eyerich K (2011) Mutual antagonism of T cells causing psoriasis and atopic eczema. N Engl J Med 365(3):231\u2013238. https:\/\/doi.org\/10.1056\/NEJMoa1104200","journal-title":"N Engl J Med"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-021-04077-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-021-04077-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-021-04077-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T21:06:06Z","timestamp":1628283966000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-021-04077-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,19]]},"references-count":17,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["4077"],"URL":"https:\/\/doi.org\/10.1007\/s00431-021-04077-0","relation":{},"ISSN":["0340-6199","1432-1076"],"issn-type":[{"value":"0340-6199","type":"print"},{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,19]]},"assertion":[{"value":"30 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the local ethics committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from the parents of all patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"N\/A","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Ondrej Hradsky: Lectures\/congress fees\/consultancy (outside the submitted work)\u2014MSD, AbbVie, Nutricia, Nestl\u00e9, Ferring, and FalkDenis Kazeka: no conflicts of interest.Ivana Copova: Lectures\/congress fees\/consultancy (outside the submitted work)\u2014MSD, Nutricia, Nestl\u00e9Katarina Mitrova: Lectures\/congress fees\/consultancy (outside the submitted work)\u2014AbbVie, TakedaTereza Lerchova: Lectures\/congress fees\/consultancy (outside the submitted work)\u2014Ferring, Nutricia, BiocodexKristyna Pospisilova: Lectures\/congress fees\/consultancy (outside the submitted work)\u2014MSD, Nutricia, Nestl\u00e9 a Mead JohnsonsMiroslava Sulovcova: no conflicts of interestKristyna Zarubova: Lectures\/congress fees\/consultancy (outside the submitted work)\u2014Nestl\u00e9Jiri Bronsky: Lectures\/congress fees\/consultancy (outside the submitted work)\u2014MSD, AbbVie, Nutricia, Nestl\u00e9, Ferring, Biocodex, and Walmark","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}